Curis Inc. licensed its bone morphogenetic protein-7 (BMP-7) program to Stryker Corp., ending a seven-month search to replace former partner Ortho Biotech Products L.P. Michael Gray, chief financial ...
Co provided an update on its bone morphogenetic protein-7, or BMP-7, program for kidney and other diseases. Preclinical research efforts on BMP-7 molecules have been ongoing at Ortho Biotech Products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback